vimarsana.com

பயன்பாடுகள் நூலகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roundup: Cough monitoring app launches, opening of robotics research company and more briefs

CONSTRUCTION BEGINS ON ROBOTICS RESEARCH CENTRE   Construction has started on a research facility for robotics and AI, based at Heriot-Watt University’s Edinburgh campus, the National Robotarium. The facility is supported by a £21 million funding from the UK government, and £1.4 million from the Scottish Government as part of the Edinburgh and South East Scotland City Region Deal. Expected to open in spring 2022, the National Robotarium will create innovative solutions to global challenges using research, product design and industry collaboration. The project will bring together academics and global companies to provide a catalyst for entrepreneurship and is expected to deliver sustainable economic benefit to Edinburgh and the UK.

Sensyne Health plc: Sensyne Health Launches First Digital Health Product in the U S

Sensyne Health plc: Sensyne Health Launches First Digital Health Product in the U.S. Sensyne Health plc (LSE: SENS) ( Sensyne or the Company or the Group ), the British Clinical AI technology company, today announces that it has launched GDm-Health, its remote monitoring solution for diabetes in pregnancy, in the U.S. with immediate effect. Sensyne s sales and marketing partner for the U.S., Cognizant, is now offering the solution to U.S. health systems and health plans via its sales force. Virtual care services powered by GDm-Health will qualify for reimbursement under remote patient monitoring codes introduced by the Centers for Medicare and Medicaid Services (CMS) in 2020.

Sensyne Health Launches First Digital Health Product in the U S – IT Business Net

Sensyne Health Launches First Digital Health Product in the U.S. OXFORD, England–(BUSINESS WIRE)–Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the British Clinical AI technology company, today announces that it has launched GDm-Health, its remote monitoring solution for diabetes in pregnancy, in the U.S. with immediate effect. Sensyne’s sales and marketing partner for the U.S., Cognizant, is now offering the solution to U.S. health systems and health plans via its sales force. Virtual care services powered by GDm-Health will qualify for reimbursement under remote patient monitoring codes introduced by the Centers for Medicare and Medicaid Services (CMS) in 2020.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.